Ogmend® Implant Enhancement System— 510(k) K223075

Name: FDA 510(k) clearance K223075
Creator: U.S. Food and Drug Administration
Published: 2023-02-27

Substantially Equivalent

Woven Orthopedic Technologies

FDA 510(k) clearance K223075 for Ogmend® Implant Enhancement System, Substantially Equivalent on 2023-02-27. Applicant: Woven Orthopedic Technologies. Device class: 2.

Clearance details

Applicant: Woven Orthopedic Technologies
Product code: Code QVI
Device class: Class 2
Regulation: 21 CFR 888.3043
Advisory panel: Orthopedic
Date received: 2022-09-30
Decision date: 2023-02-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Manchester, CT, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code QVI

view all

K233223 — OGmend® Implant Enhancement System2023-10-26

Data sourced from openFDA. This site is unofficial and independent of the FDA.